News | March 12, 2015

St. Vincent Heart Center First in Indiana in AAA Procedure Trial

Indiana surgeon first to use Nellix EndoVascular Aneurysm Sealing System to treat abdominal aortic aneurysms

St. Vincent Heart Center, Nellix EVAS, Indiana, aneurysm repair, stent graft

Image courtesy of Endologix Inc.

March 12, 2015 — St.Vincent Heart Center is first in Indiana and second in the nation to participate in a clinical study for the Nellix EndoVascular Aneurysm Sealing System (EVAS), a surgical procedure designed to repair an abdominal aortic aneurysm (AAA). Leading the clinical trial, sponsored by Endologix Inc., in Indiana is Sajjad Hussain, M.D., vascular surgeon with St.Vincent Medical Group at St.Vincent Heart Center. 

Robert Bodish, 72-year-old Indianapolis resident, first learned of his abdominal aortic aneurysm after receiving a computed tomography (CT) scan for a different medical ailment. After his physicians continued to monitor the size of his aneurysm, it was determined in January that Bodish qualified to participate in the clinical trial. Having gone through open heart surgery in 2012, Bodish is grateful for the lifesaving procedure and has been pleasantly surprised as to how quickly he has recovered and been able to return to his daily routine.

AAA is an enlarged and weakened section, or “ballooning” of the aorta. Infrarenal AAA occurs below the renal arteries – blood vessels that lead to the kidneys – that are prone to rupture and often results in death.

Traditionally, many AAAs have been repaired through two small incisions in the groin by lining the inside of the aneurysm with a stent graft that allows the blood to flow through it down to the legs and prevents blood from filling the aneurysm sac. A significant number of these patients require secondary procedures to keep blood from entering the aneurysm sac even with the stent graft in place.

The Nellix EVAS system is a new generation of AAA surgery designed to seal the entire aneurysm through two small incisions similar to the stent graft. However, the new concept in this device includes filling the space around the stents within the aneurysm with two bags filled with a solution that becomes a solid substance within a few minutes, thus preventing the risk of any blood from trickling back into the sac. The procedure is expected to significantly decrease the need for a secondary procedure in comparison with traditional surgery and other associated risks. Nellix is the first and only EVAS product that has been developed to simplify procedures, reduce re-interventions and expand the treatable patient population.

According to the Centers for Disease Control and Prevention, aortic aneurysms were the primary cause of more than 10,500 deaths and contributing cause in more than 17,200 deaths in the United States in 2009.

For more information: www.bestheartcare.com

Related Content

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Gore Announces First-in-Human Use of Gore TAG Conformable Thoracic Stent Graft
News | Stent Grafts| July 17, 2017
W. L. Gore & Associates Inc. announced the first patient implant of the Gore TAG Conformable Thoracic Stent Graft...
New Paper Highlights Success of Advanced Treatments in Complex Aortic Aneurysm Repair
News | Endovascular Aortic Repair| May 23, 2017
Significant success has been achieved in treating complex proximal aneurysms using a combination of fenestrated and...
News | Stent Grafts| April 06, 2017
Endologix Inc. announced that the first patients were treated in the Expanding Patient Applicability with Polymer...
abdominal aortic aneurysm, AAA, gender differences, women vs. men, endovascular repair, Journal of Vascular Surgery study
News | Endovascular Aortic Repair| April 05, 2017
Following repair of abdominal aortic aneurysms (AAA), women appear to have more unfavorable outcomes than men in terms...
Gore, Viabahn VBX Balloon Expandable Endoprosthesis, stent graft, iliac artery, FDA approval
Technology | Stent Grafts| January 31, 2017
W. L. Gore & Associates (Gore) announced that the Gore Viabahn VBX Balloon Expandable Endoprosthesis (VBX Stent...
Lombard Medical, Aorfix endovascular stent graft, Japanese regulatory approval, IntellFlex LP Delivery System
News | Stent Grafts| January 11, 2017
January 11, 2017 — Lombard Medical Inc.
stent grafts, fluid flow model, clotting risk, Journal of Vascular Surgery

An anterior view is shown of the geometries of each of the graft configurations: (A) fenestrated, (B) antegrade branched, (C) retrograde branched, and (D) manifold stent graft. Image courtesy of Taylor Suess, et al.

News | Stent Grafts| January 05, 2017
January 5, 2017 — Whether patients with mechanical heart valves and stents must take blood thinners depends on how ef
Sponsored Content | Videos | Artificial Intelligence| December 19, 2016
At RSNA 2016, the key buzzwords were “deep learning,” “machine learning” and “artificial intelligence.” Vendors and m
News | Stent Grafts| December 13, 2016
Lombard Medical Inc. announced that its Altura endovascular stent graft system was featured in a scientific...
Overlay Init